Correlation Between Iteos Therapeutics and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Design Therapeutics, you can compare the effects of market volatilities on Iteos Therapeutics and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Design Therapeutics.
Diversification Opportunities for Iteos Therapeutics and Design Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Iteos and Design is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Design Therapeutics go up and down completely randomly.
Pair Corralation between Iteos Therapeutics and Design Therapeutics
Given the investment horizon of 90 days Iteos Therapeutics is expected to under-perform the Design Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Iteos Therapeutics is 2.56 times less risky than Design Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Design Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 553.00 in Design Therapeutics on August 28, 2024 and sell it today you would earn a total of 62.00 from holding Design Therapeutics or generate 11.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iteos Therapeutics vs. Design Therapeutics
Performance |
| Timeline |
| Iteos Therapeutics |
| Design Therapeutics |
Iteos Therapeutics and Design Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iteos Therapeutics and Design Therapeutics
The main advantage of trading using opposite Iteos Therapeutics and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.| Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
| Design Therapeutics vs. Eliem Therapeutics | Design Therapeutics vs. Scpharmaceuticals | Design Therapeutics vs. Milestone Pharmaceuticals | Design Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |